Lymphatic vessel activation in cancer

被引:36
作者
Cassella, M [1 ]
Skobe, M [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Derlad H Ruttenberg Canc Ctr, New York, NY 10029 USA
来源
LYMPHATIC CONTINUUM: LYMPHATIC BIOLOGY AND DISEASE | 2002年 / 979卷
关键词
lymphangiogenesis; lymphatic endothelium; cancer metastasis; VEGF-C; VEGF receptor;
D O I
10.1111/j.1749-6632.2002.tb04873.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Metastasis of most cancers occurs primarily through the lymphatic system, and the extent of lymph node involvement is the most important prognostic. indicator. While the importance of the lymphatic system as a pathway for metastasis has been well recognized, there is very little information available about the mechanisms by which tumor cells interact with the lymphatics. Recently, production of the lymphangiogenic factor VEGF-C has been detected in tumors, and the significance of VEGF-C-mediated lymphangiogenesis for tumor metastasis has been demonstrated. Increased lymphatic vessel density has been found associated with certain tumors. The mechanisms by which tumor cells gain access to and enter lymphatic vessels are critical issues that need to be addressed in the future. In contrast to the prevailing view that has assigned to the lymphatic system a passive role in the metastatic process, our results indicate the importance of lymphatic vessel activation in tumor dissemination.
引用
收藏
页码:120 / 130
页数:11
相关论文
共 63 条
[1]   Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues [J].
Akagi, K ;
Ikeda, Y ;
Miyazaki, M ;
Abe, T ;
Kinoshita, J ;
Maehara, Y ;
Sugimachi, K .
BRITISH JOURNAL OF CANCER, 2000, 83 (07) :887-891
[2]  
André T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO
[3]  
2-5
[4]  
Beasley NJP, 2002, CANCER RES, V62, P1315
[5]  
Birner P, 2000, ANTICANCER RES, V20, P2981
[6]  
Birner P, 2001, INT J CANCER, V95, P29, DOI 10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO
[7]  
2-W
[8]   Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features [J].
Bunone, G ;
Vigneri, P ;
Mariani, L ;
Butó, S ;
Collini, P ;
Pilotti, S ;
Pierotti, MA ;
Bongarzone, I .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1967-1976
[9]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[10]  
Carreira CM, 2001, CANCER RES, V61, P8079